Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Contact us

Growth capital for biotechnology
and life sciences - Finance Day 2024

A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also delighted to meet many of our partners and clients again and talk to them about the importance of risk management and insurance solutions.

The startup panel was also interesting and once again demonstrated the innovative spirit of the industry. Ten companies were selected for this, nine of which were even presented in person by a founder. Take a look at the companies and if you are interested in the product or an investment, please contact the ladies or gentlemen directly. We are keeping our fingers crossed! 

  1. Better Basics Laborbedarf GmbH(Mario Schneider)
  2. Intu Diagnostics GmbH(Dr. Dirk Kuhlmeier )
  3. Pacifico Biolabs GmbH(Washington Logroño)
  4. Dr. Purus Enorm Smart Technik GmbH(Dr. Bo Liu)
  5. goodBot GmbH(Dr. Julius Wiener)
  6. hema.to GmbH(Dr. Karsten Miermanns)
  7. IRUBIS GmbH(Anja Müller)
  8. Opto Biolabs GmbH(Dr. Kathrin Brenker)
  9. Safia Technologies GmbH(Dr. Timm Schwaar)
  10. CamSens GmbH(Enrika Barreto) 
Risk Partners at the Finance Days
Flyer Finance Days 2024

In addition, the challenges of the financing environment were again discussed from various perspectives. The desire for a European capital market that would combine the strengths of Frankfurt, Euronext and NASDAQ Europe was articulated fairly unanimously. From our point of view as a specialist insurance broker, this is also desirable, although the standardization of the liability framework would certainly become even more challenging, so that different solutions for each stock exchange would no longer be necessary, as is currently the case.  

In conclusion, we are delighted to have been part of these events and will be back at the next one in Leipzig. Thanks also to the team of Plattform Life Sciences and Going Public Media AG for the great organization and the successful framework of the event! We had a lot of fun. 

Also read our other blog posts

Being Public

Earnings Call: one 0 too many - the Lyft CEO mistake

"Look, it was a bad mistake, and that's on me," CEO of LYFT Inc. The incident and possible insurance coverage. You may have also heard about the recent incident with LYFT. In the quarterly earnings report, LYFT originally stated that profit margins were up 500 basis points before correcting this to 50 basis points during the conference call. This clerical error caused the stock price to rise more than 60% in after-hours trading. This situation is exactly what investor relations teams that

Read more "
February 17, 2024
Venture Capital

We provide information on liability risks for VC funds in the VC Magazine

In December, we were asked by VC-Magazin whether we could provide insights into liability and risk management issues relating to venture capital funds. With pleasure! Together with the team, Florian not only provided insights into current challenges, but also suggested practical solutions to effectively minimize and sensibly transfer the risks of a VC fund. In the VC Magazine article, you will therefore find: added value of customized insurance concepts for VC funds (focus: D&O/E&O insurance #Moonshotprotect), key measures for risk prevention (learning curve from our claims world), indemnifying contractual provisions as a preventive measure, and

Read more "
January 26, 2024
Being Public

New SEC Ruling: Transatlantic convergence in dealing with cyber security incidents

Foreign Filers / Private Issuers watch out! 2023 brought further harmonization of European and US standards for cyber incident reporting. According to the SEC Ruling, all companies listed on the US stock exchange are now required to publicly report significant data security incidents to the SEC within four working days. In addition, they must outline in their annual report (10-K) their procedures for identifying and addressing material cybersecurity risks, including the role of the board of directors. Note: This rule also applies to foreign private issuers (e.g., German companies that issue a

Read more "
January 17, 2024
Your question has not been answered?
We will be happy to advise you in a free initial consultation.
Get advice now

Receive the Life Sciences Insurance Protection Guide free of charge!

Everything you need to know to optimally protect you and your life sciences / biotech company.